Health Condition 1: K053- Chronic periodontitis
Conditions
Interventions
Intervention1: probiotic with scaling and root planing: Participants in the intervention group will receive probiotic supplementation twice daily for 21 days Tab Bifilac Tablets India Private Limited,
Sponsors
Banaras Hindu University
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 18 to 65 years Patients having moderate to severe chronic generalized periodontitis (more than equal to 3 mm clinical attachment loss involving more than 30 percent of sites) Presence of halitosis, confirmed by organoleptic assessment Patients who had not taken any antibiotics during the previous 3 months or anti-inflammatory drugs in the last month Patients who had not participated in any clinical trial during the previous month Who had not undergone any surgical or non-surgical therapy 6 months prior to the study Ability to provide informed consent for participation in the study. Patients who agreed for regular follow ups.
Exclusion criteria
Exclusion criteria: Patients with history of drug allergy. Pregnant or breastfeeding women. Patients wearing orthodontic appliances or any removable prosthesis Patient with systemic ailments Patients not consenting to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Probing Pocket Depth (PPD) from baseline to 1, 2, and 3 months. Change in Clinical Attachment Level (CAL) over the same intervals. Reduction in halitosis scores, assessed using organoleptic method.Timepoint: Change in Probing Pocket Depth (PPD) from baseline to 1, 2, and 3 months. Change in Clinical Attachment Level (CAL) over the same intervals. Reduction in halitosis scores, assessed using organoleptic method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Gingival Index (GI) from baseline to follow-up visits. Perceived improvement in breath freshness Oral discomfort or ease of probiotic use Incidence of adverse effects or complications related to probiotic use (e.g., gastrointestinal upset, allergic reactions). Need for retreatment or additional interventions during the 3-month follow-up.Timepoint: 1 month 2 month 3 month | — |
Countries
India
Contacts
Public ContactAishwarya Pandey
Banaras Hindu University
Outcome results
None listed